Fortis Healthcare Ltd

Fortis Health. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Fortis Healthcare Ltd

₹ 445 -1.14%
25 Apr 4:03 p.m.
fortishealthcare.com BSE: 532843 NSE : FORTIS
About

FHL was incorporated in February 1996. The company’s first healthcare facility became operational in Mohali, Punjab in 2001. It is a leading integrated healthcare service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics and day care specialty facilities. Currently, the company operates its healthcare delivery services in India, Nepal, Dubai and Sri Lanka with 36 healthcare facilities with approximately 4,000 operational beds. [1]

Company controls its diagnostics business through its 57% owned subsidiary SRL Limited. It is amongst the largest private diagnostics chains. It has a presence in over 600 cities and towns, with an established strength of 415 laboratories, 8,200 direct clients and 1,400 Collection Centers. [2]

Key Points

Network[1]
Fortis operates 27 hospitals (including JVs) with ~4,500 operational beds, 5,500+ Doctors, 6,500+ Nurses and ~24,000 employees (including Agilus). 4 facilities are JCI accredited and 21 NABH Accredited.
**State-wise Beds Split - **
NCR - 1722
West Bengal - 335
Chattisgarh - 70
Karnataka - 620
Maharashtra - 770
Rajasthan - 275
Punjab - 774

Website BSE NSE
  • Market Cap ₹ 33,562 Cr.
  • Current Price ₹ 445
  • High / Low ₹ 470 / 254
  • Stock P/E 439
  • Book Value ₹ 119
  • Dividend Yield 0.22 %
  • ROCE 1.69 %
  • ROE 0.61 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Stock is trading at 3.73 times its book value
  • The company has delivered a poor sales growth of 9.81% over past five years.
  • Company has a low return on equity of 0.11% over last 3 years.
  • Earnings include an other income of Rs.202 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
184 195 204 221 228 210 247 266 262 277 289 294 291
157 198 179 188 190 191 215 228 226 250 254 255 242
Operating Profit 27 -3 25 33 38 19 32 38 36 28 35 40 49
OPM % 15% -2% 12% 15% 17% 9% 13% 14% 14% 10% 12% 13% 17%
69 20 33 33 35 16 19 106 42 30 31 110 32
Interest 36 34 33 32 32 33 28 28 25 25 23 21 19
Depreciation 28 28 28 28 28 28 28 29 29 29 25 25 25
Profit before tax 32 -45 -2 6 14 -27 -5 87 24 3 18 104 36
Tax % 34% 9% 26% 34% 37% 9% -51% 5% 18% 41% 27% 8% 36%
21 -41 -2 4 9 -24 -8 82 19 2 13 95 23
EPS in Rs 0.28 -0.54 -0.02 0.06 0.11 -0.32 -0.10 1.09 0.26 0.03 0.17 1.26 0.30
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
281 353 369 611 612 645 659 656 702 633 863 1,053 1,151
276 353 449 758 737 792 697 780 633 605 747 919 1,000
Operating Profit 5 -0 -80 -148 -125 -146 -38 -123 69 28 116 134 151
OPM % 2% -0% -22% -24% -20% -23% -6% -19% 10% 4% 13% 13% 13%
311 189 229 220 166 165 70 522 809 248 118 197 202
Interest 103 134 91 81 65 106 64 192 160 141 130 106 88
Depreciation 12 23 17 27 25 27 29 27 97 111 113 116 105
Profit before tax 201 32 41 -36 -50 -114 -60 180 621 24 -9 109 160
Tax % 0% 46% 42% 5% 19% 34% -6% 31% 17% 83% -48% 12%
201 17 24 -34 -40 -75 -64 123 513 4 -13 96 133
EPS in Rs 4.97 0.43 0.52 -0.73 -0.87 -1.44 -1.23 1.63 6.80 0.06 -0.18 1.27 1.76
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 78%
Compounded Sales Growth
10 Years: 12%
5 Years: 10%
3 Years: 14%
TTM: 17%
Compounded Profit Growth
10 Years: 14%
5 Years: 161%
3 Years: -56%
TTM: 93%
Stock Price CAGR
10 Years: 16%
5 Years: 26%
3 Years: 29%
1 Year: 72%
Return on Equity
10 Years: 1%
5 Years: 2%
3 Years: 0%
Last Year: 1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 405 405 463 463 463 518 519 755 755 755 755 755 755
Reserves 2,795 2,796 3,247 3,217 3,284 3,754 3,708 7,608 8,122 8,127 8,114 8,209 8,241
Preference Capital 4 4 0 0 0 0 0 0 0 0 0 0
1,107 1,014 1,279 1,234 1,076 647 555 1,478 1,361 1,380 1,193 785 732
190 264 171 246 215 242 234 279 343 320 365 620 607
Total Liabilities 4,498 4,478 5,160 5,159 5,039 5,161 5,016 10,120 10,581 10,582 10,426 10,369 10,335
85 118 146 190 172 186 203 180 906 853 770 492 464
CWIP 49 73 121 169 182 199 166 165 33 7 6 3 280
Investments 2,310 2,406 2,795 2,411 2,428 3,603 3,658 8,310 8,153 8,898 8,845 8,848 8,773
2,054 1,882 2,097 2,389 2,257 1,174 989 1,466 1,489 824 804 1,027 818
Total Assets 4,498 4,478 5,160 5,159 5,039 5,161 5,016 10,120 10,581 10,582 10,426 10,369 10,335

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
100 1 -45 -144 -761 22 -15 -61 100 32 76 198
-723 312 -521 294 394 -72 245 -4,688 810 28 238 205
599 -219 484 -170 370 45 -292 4,792 -972 6 -320 -395
Net Cash Flow -23 95 -82 -20 3 -5 -62 43 -62 66 -6 8

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 81 96 86 57 61 43 39 47 42 43 32 34
Inventory Days 20 17 16 18 15 14 19 17 25 21 25 18
Days Payable 215 170 172 240 289 340 392 542 525 520 494 572
Cash Conversion Cycle -115 -57 -70 -165 -213 -284 -334 -479 -457 -456 -438 -520
Working Capital Days 1,830 525 1,283 354 84 44 -23 19 7 45 25 32
ROCE % 8% 4% 3% 0% 1% -0% 1% 5% 9% 1% 1% 2%

Shareholding Pattern

Numbers in percentages

1 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17%
30.57% 29.33% 30.08% 29.82% 29.66% 30.59% 31.01% 31.22% 30.03% 26.31% 23.72% 23.24%
15.33% 15.79% 15.67% 16.90% 17.60% 20.02% 20.38% 20.69% 22.17% 26.55% 29.42% 31.14%
22.94% 23.71% 23.08% 22.12% 21.57% 18.22% 17.44% 16.92% 16.65% 15.97% 15.71% 14.44%
No. of Shareholders 1,44,6341,66,7431,54,5721,56,8811,60,7621,58,4551,43,5191,37,8941,35,0471,31,5161,35,6641,57,165

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls